Maude Schneider is assistant professor at the Faculty of Psychology and Educational Sciences of the University of Geneva since 2019 where she heads the Clinical Psychology Unit for Intellectual and Developmental Disabilities. Maude Schneider is working as a clinician and researcher in the field of neurodevelopmental disorders. Using a combination of clinical and cognitive approaches as well as digital phenotyping, her research aims to explore the mechanisms underlying social and mental health difficulties of adolescents and young adults with neurodevelopmental conditions.

In the first part of the presentation, Maude Schneider will present how Ecological Momentary Assessment (EMA) techniques can be used for symptom monitoring and for the exploration of relevant psychological mechanisms underlying the clinical expression of symptoms. In the second part of the presentation, she will highlight how information collected in the flow of daily-life could be used to personalize interventions in the fieldof mental health.

Corrado Sandini studied medicine at the University of Genova in Italy. He then pursued a PhD in Neuroscience at the University of Geneva focusing on the developmental of computational approaches, namely dynamic network analysis, to characterize neurodevelopmental and clinical pathways of vulnerability to psychosis in 22q11DS. Since his PhD he divides his time as a resident in child and adolescent psychiatry at the Fondation Pole Autisme in Geneva and research activity. He has been supported by a clinical scientist grant of the NNCR Synapsy to study the role of sleep disturbances in 22q11DS and more recently by an the SNSF Ambizione Fellowship to study the contribution of sleep disturbances in contributing to affective comorbidities in ADHD using an ecological digital phenotyping approach and network analysis techniques.

Corrado will highlight the role that computational analysis techniques might play in the clinical translation of these technologies, by helping clinicians navigate the complexity of digital phenotyping data in a more intuitive and informative way. He will briefly discuss how increasing precision of clinical assessments could help us shed light on differential underlying neurobiological mechanisms.

After graduating from the Liceo Cantonale in Locarno, Maurizia Franscini studied medicine first in Bern and then in Zurich, earning her MD in 1995. In 2006, she obtained her specialization in child and adolescent psychiatry and psychotherapy. Since 2000, she been working at the University Psychiatric Clinic in Zurich, where she currently holds the position of head physician. She developed and implemented the therapy App Robin Z at the University Hospital of Child and Adolescent Psychiatry and Psychotherapy, Zürich.

The Robin therapy program was developed in the early recognition center of Zurich with the aims to improve quality of life and daily functioning of adolescents at high risk for psychosis. In this presentation, the Robin therapy program will be presented and the hurdles and special features of treatment of adolescents will be discussed.

Professor Sterzer studied medicine at the Ludwig Maximilian University Munich and at the Harvard Medical School and obtained his MD in 2001. He habilitated in Experimental Psychiatry at the Charité Berlin. He is board certified in Neurology and Psychiatry. From 2011 he was Professor of Psychiatry and Computational Neuroscience at the Charité and since 2022 he holds position of Professor of Translational Psychiatry, University of Basel, and Chief Physician, Zentrum für Diagnostik und Krisenintervention, Universitäre Psychiatrische Kliniken Basel. His research focuses on predictive coding and computational psychiatry.

There has been an increasing interest in theory-driven computational approaches towards explaining psychiatric disorders in recent years. Philipp will present a Bayesian predictive processing account of psychosis and empirical evidence from recent behavioral, neuroimaging and pharmacological intervention studies supporting this account. Moreover, he will discuss potential implications of such a theory-driven approach for the development of biological and psychological treatments.